FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Bowel topics
Bowel Disease
Inflammatory Bowel Disease
Irritable Bowel Syndrome
Inflammation
Mercaptopurine
Probiotics
Abdominal Pain
Discomfort
Bowel Movement
Gastrointestinal
Ulcerative Colitis
Rheumatoid Arthritis
Jejunal Tube
Spring Mechanism
Small Bowel

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Bowel patents



      
           
This page is updated frequently with new Bowel-related patent applications. Subscribe to the Bowel RSS feed to automatically get the update: related Bowel RSS feeds. RSS updates for this page: Bowel RSS RSS


Date/App# patent app List of recent Bowel-related patents
05/21/15
20150141800
 Management, assessment and treatment planning for inflammatory bowel disease patent thumbnailnew patent Management, assessment and treatment planning for inflammatory bowel disease
Discussed herein is an image processing device and a corresponding method for assessing inflammatory bowel diseases. A plurality of dynamic mri sequence of images of a bowel that include peristalsis information of the bowel and static mri image(s) of the bowel that identify at areas of inflammation, stenosis, and increased mural thickness of the bowel are processed.
Children's National Medical Center
05/21/15
20150141631
 Pyrazole derivative and use thereof for medical purposes patent thumbnailnew patent Pyrazole derivative and use thereof for medical purposes
The present invention provides pyrazole derivatives, uses thereof for medical purposes and so on. More particularly, the present invention relates to pharmaceuticals useful for the prevention or treatment of constipation, which comprise as an active ingredient 3-(3-{4-[3-(β-d-glucopyranosyloxy)-5-isopropyl-1h-pyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)-2,2-dimethylpropionamide, or a pharmaceutically acceptable salt thereof.
Kissei Pharmaceutical Co., Ltd.
05/21/15
20150141523
 Compounds for use in the treatment of autoimmune inflammatory disease patent thumbnailnew patent Compounds for use in the treatment of autoimmune inflammatory disease
And salts thereof is useful in the prophylaxis or treatment of inflammatory bowel disease or other inflammatory autoimmune diseases with similar aetiology involving t-cell proliferation or or function.. .
05/21/15
20150141472
 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use patent thumbnailnew patent Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “apsac compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (copd), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc..
Pimco 2664 Limited
05/21/15
20150140175
 Human milk permeate compositions and methods of making and using same patent thumbnailnew patent Human milk permeate compositions and methods of making and using same
This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk. The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease..
Prolacta Bioscience
05/21/15
20150140161
 Methods of improving tolerance related to feeding in an infant, toddler, or child patent thumbnailnew patent Methods of improving tolerance related to feeding in an infant, toddler, or child
Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component..
Abbott Laboratories
05/21/15
20150139990
 Human monoclonal antibody patent thumbnailnew patent Human monoclonal antibody
The invention provides a method for the prophylaxis, improvement, or treatment of inflammatory bowel disease, multiple sclerosis, and psoriasis by administering to a subject an effective amount of an isolated anti-human cd81 antibody capable of binding to a peptide region consisting of the amino acid sequence of amino acid numbers 80 to 175 of seq id no:22.. .
Sumitomo Dainippon Pharma Co., Ltd.
05/14/15
20150133507
 Pharmaceutical compositions comprising glitazones and nrf2 activators patent thumbnailPharmaceutical compositions comprising glitazones and nrf2 activators
The invention relates to pharmaceutical compositions comprising ppar agonists and nrf2 activators and methods of using combinations of ppar agonists and nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.. .
05/14/15
20150133373
 Transmucosal delivery of engineered polypeptides patent thumbnailTransmucosal delivery of engineered polypeptides
Formulations are provided that comprise compounds having inter alia good duration of action, high potency and/or convenient dosing regimens, and a permeation enhancer for transmucosal administration. The compounds are engineered polypeptides which incorporate an albumin binding domain in combination with one or more biologically active polypeptides.
05/14/15
20150133330
 Methods and compositions useful for diagnosing inflammatory bowel disease-associated neoplasia patent thumbnailMethods and compositions useful for diagnosing inflammatory bowel disease-associated neoplasia
The present invention relates to the field of biomarkers. More specifically, the present invention relates to the use of micrornas to diagnose and monitor various diseases such as cancer.
05/14/15
20150132836

Method and system for detecting lymphosarcoma in cats using biomarkers


The invention provides a method and system for developing and using diagnoses of lymphosarcoma in feline subjects using thymidine kinase (tk) and haptoglobin (hp) as biomarkers. The invention provides a method for obtaining the level of each biomarker and computing an index for a feline subject.
05/14/15
20150132466

Nutritional products including a novel fat system including fatty acids


Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component..
05/14/15
20150132387

Treatment of inflammatory bowel disease


The invention relates to the treatment of inflammatory bowel disease, also termed ibd, including ulcerative colitis and crohn's disease. To this end, the invention proposes clinoptilolite having a particle size between 0.2 and 1 μm for use in the treatment of inflammatory bowel disease, also termed ibd, in mammals and humans.
05/07/15
20150125538

Compositions and methods for oxalate reduction


The present invention comprises methods and compositions for the reduction of oxalate in humans. For example, the invention provides methods and compositions for the delivery of one or more oxalate-reducing enzymes embedded in particle compositions.
Oxthera Intellectual Property Ab
05/07/15
20150125523

Antisense compositions and methods of making and using same


The present invention provides pharmaceutical formulations for oral administration of antisense oligonucleotides, such as antisense oligonucleotides against smad7. The pharmaceutical formulations can be used to treat crohn's disease, ulcerative colitis and chronic inflammatory bowel disease..
Nogra Pharma Limited
04/30/15
20150119467

Methods for treatment of pelvic pain and/or comorbid conditions


Methods, systems, devices, and medicaments are provided for locally administering to a pelvic-area organ or tissue structure in a patient at least one drug continuously or continually over a treatment period of 24 hours or more in an amount effective to achieve a therapeutic effect in another organ or tissue structure by means of shared or convergent pelvic afferent pathways. The methods systems, devices, and medicaments can be used in the treatment of ic/bps, chronic pelvic pain, vulvodynia, orchialgia, urethral syndrome, dysparenia, chronic prostatitis, chronic pelvic pain, levator ani syndrome, irritative bowel syndrome, or a combination thereof.
Allergan, Inc.
04/30/15
20150119344

Compositions and methods for the treatment of cardiovascular and neurological diseases


The invention relates to the compounds of formula i, formula ii and formula iii or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula i, formula ii or formula iii and methods for the treatment of cardiovascular and neurological diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection.
04/30/15
20150119321

System and losing weight


A unique combination of weight loss modalities that produce 20-40 pounds of weigh loss in a six week treatment period. Treatment includes a meal plan chosen to provide adequate protein and nutrition during dieting and to assist metabolism of toxins created from the release of stored fat, high amounts of fiber to assist in collecting toxins and fat in the elimination system and to encourage peristaltic action in the bowel, a bowel toner to further increase peristaltic action in the bowel, stimulating liver functions of fat and toxins.
04/30/15
20150118296

Controlled release budesonide compositions


The present invention relates to controlled release pharmaceutical compositions comprising budesonide. The invention also relates to processes for the preparation of such compositions and using those compositions in the treatment of inflammatory bowel disease and irritable bowel syndrome including mild to moderate ulcerative colitis..
Cadila Healthcare Limited
04/30/15
20150118217

Treatment of disease conditions via administration of dna repair enzyme


The present invention is directed to compositions and methods of preserving viability of islets of langerhans for transplantation, and treating various disease and other abnormal or pathological conditions, including inflammatory bowel disease, ischemic heart disease, acute lung injury, acute respiratory distress syndrome and radiation-induced brain injury, with dna repair enzymes that are directed to the mitochondria.. .
University Of South Alabama
04/23/15
20150111937

Compositions and methods for treating intestinal hyperpermeability


The present invention provides methods, compositions, and kits for treating intestinal hyperpermeability in a subject in need thereof, including conditions such as hyperglycemia and underlying diseases such as diabetes, autism, fibromyalgia, inflammatory bowel disease (ibd), graft versus host disease (gvhd), hiv/aids, multiple organ dysfunction syndrome, irritable bowel syndrome (ibs), celiac disease, eczema, psoriasis, acute pancreatitis, parkinson's disease, depression, chronic fatigue syndrome, asthma, multiple sclerosis, arthritis, ankylosing spondylitis, nonalcoholic fatty liver disease, alcoholic cirrhosis, environmental enteropathy, or kwashiorkor.. .
04/23/15
20150111878

Compositions and methods for treating intestinal hyperpermeability


The present invention provides methods, compositions, and kits for treating intestinal hyperpermeability in a subject in need thereof, including underlying diseases such as diabetes, autism, fibromyalgia, inflammatory bowel disease (ibd), graft versus host disease (gvhd), hiv/aids, multiple organ dysfunction syndrome, irritable bowel syndrome (ibs), celiac disease, eczema, psoriasis, acute pancreatitis, parkinson's disease, depression, chronic fatigue syndrome, asthma, multiple sclerosis, arthritis, ankylosing spondylitis, nonalcoholic fatty liver disease, alcoholic cirrhosis, environmental enteropathy, or kwashiorkor.. .
04/23/15
20150111865

Trk-inhibiting compound


(wherein all symbols represent the same meanings as described in the specification), a salt thereof, an n-oxide thereof, a solvate thereof or a prodrug thereof is useful as a drug component having trk-inhibiting activity in prophylaxis and/or therapy of diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or chagas disease.. .
04/23/15
20150110838

Compositions and methods for treating crohn's disease and related conditions and infections


In alternative embodiments, the invention provides a “triple combination” therapy for treating, ameliorating and preventing crohn's disease (or crohn syndrome, terminal or distal ileitis or regional enteritis) or related disorders and conditions in mammals, such as paratuberculosis in mammals, or johne's disease, including genetically-predisposed and chronic disorders, where the microbial or bacterial flora of the bowel is at least one causative or symptom-producing factor; and compositions for practicing same. In alternative embodiments, methods and compositions of the invention comprise or comprise use of therapies, medications, formulations and pharmaceuticals comprising active agents that can suppress or eradicate the microbiota super-infection that causes crohn's disease or paratuberculosis infection in mammals.
04/23/15
20150110834

Fungal mycobiome as probiotics, diagnostics and therapeutics


The present invention relates to methods of using fungal mycobiome as a means of treating and/or diagnosing diseases in a subject. In one embodiment, the present invention provides a method of diagnosing inflammatory bowel disease based on the composition of fungal strains present in the gut of a subject, and treating the subject by administering a probiotic biotherapy.
Cedars-sinai Medical Center
04/23/15
20150110718

Methods and kits for determining a placebo profile in subjects for clinical trials and for treatment of patients


The present invention is directed to methods and assays for identifying subjects participating in clinical trials that may exhibit a placebo response and identifying treatments for subjects with varying degrees of placebo responses. In one aspect, a method of selecting subjects to participate in a clinical trial is disclosed.
Biometheus Llc


Popular terms: [SEARCH]

Bowel topics: Bowel Disease, Inflammatory Bowel Disease, Irritable Bowel Syndrome, Inflammation, Mercaptopurine, Probiotics, Abdominal Pain, Discomfort, Bowel Movement, Gastrointestinal, Ulcerative Colitis, Rheumatoid Arthritis, Jejunal Tube, Spring Mechanism, Small Bowel

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Bowel for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bowel with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         















0.2318

3582

459291 - 0 - 71